500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.
The researchers, including those from the University of Texas Health Science Center at San Antonio (UT Health San Antonio) in the United States, developed two molecules that inhibit the molecular 'scissor' enzyme used by the coronavirus called SARS-CoV-2-PLpro.
Led by Congress leader Rahul Gandhi, the Opposition members in the Lok Sabha demanded sacking of Union minister Ajay Mishra from the government in connection with the Lakhimpur Kheri violence.
The over five-year-long search to find Geeta's family led to Parbhani in Maharashtra, where she is now being trained in sign language by Pahal, an NGO working for the hearing and speech impaired.
He congratulated the company's management on its science and innovation platform.
The study, published in the Journal of Pediatrics, also challenges the current hypothesis that because children have lower numbers of immune receptors for SARS-CoV2, the virus that causes COVID-19, this makes them less likely to become infected or seriously ill.
The researchers discovered that just a 4.6 ppb reduction in long-term exposure to NO2 would have prevented 14,672 deaths among those who tested positive for the virus.
'If the government does its job of vaccinating all the population with the booster dose, and also monitoring the virus, and we do our job of wearing a mask and avoiding crowded places, we will be free of this virus in a few months.' time.'
'The ICMR and Biological E Limited, Hyderabad, have developed highly purified antisera (raised in animals) for prophylaxis and treatment of COVID-19,' the apex health research body said on Thursday. The 'antisera' is yet to undergo human clinical trials to establish its safety and efficacy and Drugs Controller General of India would be approached soon in this regard, Dr Samiran Panda, the head of epidemiology and communicable diseases at the ICMR said.
'Putting tanks on the Ladakh border is not enough to combat China, what is needed to ensure resilience against any cyber-attacks or attacks in outer space or China flexing its economic muscle, as it did with Australia.'
Named after Satyajit Ray's famed detective, the Feluda test, which is priced at Rs 500 and can deliver a result in 45 minutes, is able to differentiate SARS-CoV-2 from other coronaviruses even if genetic variations between them are minute.
'Wearing masks, washing our hands, all those things are barriers to transmissibility, or contagion, but as the virus becomes more contagious it statistically is better at getting around those barriers'
Abnormal weight gain or loss, excessive fatigue and prolonged confusion are some of the early sign of thyroid issues, warns Nohita Cheva.
5 things you must know about the lady who has won bashful Boom Boom's heart.
Taking a dig at China, Defence Minister Rajnath Singh on Sunday said 'some irresponsible nations' with their narrow partisan interests and hegemonic tendencies are coming up with wrong definitions of the UN Convention on the Law of the Sea.
In 2003, the United States Congressional Research Service asserted that there is a danger that India may develop a bio weapons programme. It claimed that 'India is believed to have an active biological defence research program as well as the necessary infrastructure to develop a variety of biological agents'. However, there is no evidence in the public domain of India ever having pursued an offensive bio weapons programme.
Vaughan said it was not a good precedent set by Australia.
The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS in New Delhi on Thursday, with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.
For the first time in Tamil Nadu, a lion has died of coronavirus while nine others in the pride have tested positive for the infection at a zoo near Chennai, an official said.
The rapid surge in cases during Delhi's fourth COVID-19 wave was mainly driven by the Delta variant, which likely has immune-evasion properties and counted for 60 per cent of the cases in April, according to a new study.
'I'm a very positive and optimistic human being.' 'You put a pile of garbage in front of me and I will find a flower in it.'
The Central Board of Secondary Education (CBSE) will announce the results online.
Health Minister Harsh Vardhan said the COVID-19 vaccine will be available in the next few months and it is estimated that by July-August 400-500 million doses will be made available for 25-30 crore people.
'Even though the hormonal drugs made me feel constantly sick, the IAAF now wants to enforce even stricter thresholds with unknown health consequences. I will not allow the IAAF to use me and my body again'
'The prioritisation of groups for COVID-19 vaccine shall be based on two key considerations -- occupational hazard and risk of exposure to infection, and the risk of developing severe disease and increased mortality'
Legendary India footballer I M Vijayan on Friday urged the country's youngsters to "get addicted to football, not to drugs". The former captain, in his message on the occasion of International Day against Drug Abuse and Illicit Trafficking, said instead of seeking a quick solution through drugs, the youngsters should head to the football ground.
Singh stressed that if Punjab was able to meet its target of administering two lakh shots a day, then its current supplies will last only three days.
Nasal droplets fall within 2 metres from a COVID-19 infected person and the aerosols can travel in air up to 10 metres, the Office of the Principal Scientific Adviser said on Thursday, adding that proper ventilation can decrease the risk of transmission.
The research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 months, while lung impairments persisted in some patients, especially those who had experienced the most severe illness with Covid-19.
Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.
'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'
The Omicron variant carries 'concerning' mutations that may make it more transmissible and allow it to evade immunity, scientists said on Monday, stressing that the one certainty in the uncertainty of the many things unknown is this -- COVID is not a short-term crisis and vaccines are still a critical tool.
The Bill was supported by the members across party lines, however, some suggested to add in its purview hospital sanitary staff, ASHA (accredited social health activist) workers and 'Corona warriors' in emergency services such as police and personnel from other departments.
The highly transmissible Delta variant of SARS-CoV-2 has mutated further to form the 'Delta plus' or 'AY.1' variant but there is no immediate cause for concern in India as its incidence in the country is still low, scientists in New Delhi said.
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
8 Asiatic lions in the zoo in have tested positive for COVID-19 after their saliva samples were thoroughly examined by CSIR-Centre for Cellular and Molecular Biology in Hyderabad, Rakesh Mishra, advisor of the premier research institute said.
Perhaps it says something more deep and profound about the time we live in and how it has shaped us, observes Aakar Patel.
'What we see today is bargaining.' 'The man's family sets a price for him and then they start bargaining.' 'He is sold to the family that offers the highest price.' 'In this market, a woman is just a commodity to be sold because if she remained at home, it is a humiliation for the family.'
'Each one of us is going through problems. My funda in life is, be nice.'
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances